Categories
Eris Lifesciences Limited — Credit Ratings, 08-05-2026: Credit Rating
08-05-2026 · 05:05 pm
India Ratings (Ind-Ra) affirmed Eris Lifesciences' Long-term Issuer, NCD, and bank facility ratings at 'IND AA' with a Stable outlook. This affirmation reflects ELL's sustained strong operating performance, competitive market position, and improved financials. Diversification across products and geographies, coupled with strengthening credit metrics and a strategic M&A focus, supported the unchanged rating.
No comments yet. Be the first to comment!